Janney Montgomery Scott
AGRX

Janney Montgomery Scott’s Agile Therapeutics AGRX Stock Holding History

Janney Montgomery Scott’s Portfolio AGRX Stock Details AGRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-10
Closed -$4K – 2476
2022
Q1 		$4K Buy
10
+5
+100% +$3.19K ﹤0.01% 2227
2021
Q4 		$5K Buy
+5
New +$7.05K ﹤0.01% 2360
2020
Q1 		– Sell
-6
Closed -$30K – 2135
2019
Q4 		$30K Buy
+6
New +$21K ﹤0.01% 2044
2018
Q1 		– Sell
-20
Closed -$108K – 2029
2017
Q4 		$108K Buy
20
+2
+11% +$18.6K ﹤0.01% 1880
2017
Q3 		$158K Buy
18
+2
+13% +$15.4K ﹤0.01% 1747
2017
Q2 		$122K Buy
+16
New +$111K ﹤0.01% 1684

Other funds holding AGRX

PA
Perceptive Advisors New York $5.06B AUM 314.02% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Jane Street
Jane Street New York $93.1B AUM 61.18% 1-Year Est. Return
IA
Investor AB Stockholm, Sweden $15.1B AUM 29.02% 1-Year Est. Return
Citigroup
Citigroup New York $157B AUM 32.99% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $121B AUM 33.93% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $564B AUM 30.12% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $77.3B AUM 36.07% 1-Year Est. Return